Finance
Market Analysts see CureVac N.V. [CVAC] gaining to $13. Time to buy?
CureVac N.V. [NASDAQ: CVAC] traded at a high on Thursday, posting a 1.72 gain after which it closed the day’ session at $2.96. The company report on April 4, 2024 at 7:15 AM that CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine
